Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study
This study provides evidence that patients adherent with patiromer use more RAASi than lower-adherence patients. Prior studies show RAASi use reduces mortality risk and kidney disease progression.
Authors
- Charuhas V. Thakar
- Nathan L. Kleinman (ORCID: https://orcid.org/0000-0001-5779-3679)
- Tejas Desai (ORCID: https://orcid.org/0000-0002-0151-9766)
Institutions
- Queen's University Belfast (GB)
- Carolinas Medical Center (US)
- Klein Buendel (United States) (US)
Publication Details
- Journal
- World Journal of Nephrology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.5527/wjn.v15.i1.113599
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00